PI
EBS icon

PFG Investments’s Emergent Biosolutions EBS Stock Holding History

PFG Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,495
Closed -$101K – 1170
2025
Q3 		$101K Hold
11,495
– – 0.01% 1054
2025
Q2 		$73.3K Buy
+11,495
New +$65.8K ﹤0.01% 989
2024
Q4 		– Sell
-27,253
Closed -$228K – 1037
2024
Q3 		$228K Buy
+27,253
New +$248K 0.01% 842

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PFG Investments's EBS Position: Q4 2025 in Review

PFG Investments sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 11,495 shares — an estimated $101K sold.

PFG Investments first reported a position in EBS in Q3 2024 and held it in 3 quarters. The position peaked at $228K in Q3 2024. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

  • PFG Investments reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
  • PFG Investments sold 11,495 Emergent Biosolutions shares in Q4 2025, an estimated $101K.
  • PFG Investments first reported a position in Emergent Biosolutions in Q3 2024 and held it in 3 quarters.
  • PFG Investments's Emergent Biosolutions position peaked at $228K in Q3 2024.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on PFG Investments's 13F filing for Q4 2025, filed 26 Jan 2026.